FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Lloyd Inc. of Iowa Thyro-Tab 0 Recall

Thyro-Tab 0

Lloyd Inc. of Iowa · Shenandoah, IA

Risk level
Class II
Reported by FDA
Dec 12, 2012
Recall ID
D-078-2013
Check your lot numberHow we source this data

Summary

Lloyd Inc. of Iowa recalled Thyro-Tab 0 starting Jul 9, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-078-2013 on Dec 12, 2012. Reason: cGMP Deviations; does not meet in process specification requirements. Status: Terminated.

Why it was recalled

cGMP Deviations; does not meet in process specification requirements

Product description

Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

Lot numbers, UPCs & expiration codes

Lot #HC31411 and #HE18711

Where it was sold

Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-078-2013
Classification
Class II
Status
Terminated
Recall initiated
Jul 9, 2012
FDA report date
Dec 12, 2012
Quantity
3,813,645 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
Lloyd Inc. of Iowa

Original FDA data

Every field from FDA enforcement report D-078-2013, exactly as published.

Show all FDA fields
City
Shenandoah
State
IA
Status
Terminated
Country
United States
Event ID
62511
Address
604 W Thomas Ave
Code information
Lot #HC31411 and #HE18711
Postal code
51601-1744
Report date
Dec 12, 2012
Product type
Drugs
Recall number
D-078-2013
Classification
Class II
Recalling firm
Lloyd Inc. of Iowa
Product quantity
3,813,645 tablets
Termination date
Nov 14, 2013
Reason for recall
cGMP Deviations; does not meet in process specification requirements
Voluntary / mandated
Voluntary: Firm initiated
Product description
Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Distribution pattern
Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Recall initiation date
Jul 9, 2012
Initial firm notification
Telephone
Center classification date
Dec 3, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-078-2013, published Dec 12, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls